Dr. Jürgen Bulitta is a Member at St. Jude Children’s Research Hospital, and previously served as an endowed Professor at the University of Florida. Trained as a general chemist, he worked on pharmacokinetics of inhaled drugs with Dr. Guenther Hochhaus since 2016. Dr. Bulitta’s research leverages mechanistic assays, dynamic in vitro infection models and computational approaches to develop innovative treatment strategies for life-threatening bacterial infections. This presentation will combine translational infectious disease approaches with lung-physiologically based pharmacokinetic (PBPK) modeling to provide a unique perspective on curing serious lung infections using inhaled drugs.
